COVID-19 disruption to cervical cancer screening in England.

ABSTRACT:

Introduction

In England, routine invitations for cervical screening were reduced between April 2020 and June 2020 due to the COVID-19 pandemic. We quantify the impact of COVID-19 disruptions on attendance and excess diagnoses of cervical cancer (CC).

Methods

Using Public Health England CC screening data on laboratory samples received in 2018 as a baseline we quantify the reduction in screening attendances due to the COVID-19 pandemic between April 2020 and March 2021 for women aged 25-64. We model the impact on excess CC diagnoses assuming once invitations resume 87.5% of women attend within 12 months and 12.5% delay screening for 3 or 5 years (depending on age).

Results

The number of samples received at laboratories was 91% lower than expected during April, 85% durin

SUBMITTER: Castanon A 

PROVIDER: S-EPMC9381684 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature